Milestone Pharmaceuticals Ownership | Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals Ownership Summary

Milestone Pharmaceuticals is owned by 20.06% institutional investors, 3.31% insiders, and 76.62% retail investors. Adage capital partners gp is the largest institutional shareholder, holding 10.51% of MIST shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.33% of its assets in Milestone Pharmaceuticals shares.

MIST Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Milestone Pharmaceuticals	20.06%	3.31%	76.62%
Sector	Healthcare Stocks	232.52%	10.72%	-143.24%
Industry	Biotech Stocks	384.56%	10.59%	-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Adage capital partners gp	6.98M	10.51%	$13.95M
Blackrock	4.97M	9.91%	$6.56M
Propel bio management	4.12M	6.20%	$8.32M
Orbimed advisors	3.22M	4.85%	$6.44M
Millennium management	2.70M	4.08%	$6.38M
Rtw investments, lp	2.51M	3.78%	$5.01M
Simplify asset management	1.51M	2.27%	$3.04M
Jane street group	1.09M	1.65%	$2.21M
Pathstone	1.00M	1.51%	$2.00M
Sphera funds management	820.00K	1.24%	$1.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	658.55K	7.48%	$1.32M
Propel bio management	4.12M	7.10%	$8.32M
Amh equity	231.67K	0.58%	$463.34K
Boxer capital management	666.67K	0.42%	$1.33M
Sphera funds management	820.00K	0.35%	$1.64M
Orbimed advisors	3.22M	0.15%	$6.44M
October effect	52.10K	0.12%	$105.24K
Cascades capital asset management	77.51K	0.07%	$156.57K
Rtw investments, lp	2.51M	0.06%	$5.01M
Simplify asset management	1.51M	0.05%	$3.04M

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	6.98M	0.02%	6.98M
Orbimed advisors	3.22M	0.15%	3.22M
Pathstone	1.00M	0.01%	1.00M
Sphera funds management	820.00K	0.35%	820.00K
Jane street group	1.09M	0.00%	684.74K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-4.05M
Morgan stanley	781.88K	0.00%	-2.19M
Nantahala capital management	-	-	-1.45M
Alta fundamental advisers	-	-	-1.40M
Simplify asset management	1.51M	0.05%	-1.33M

New Positions

Holder	Shares	% Assets	Change	Value
Adage capital partners gp	6.98M	0.02%	6.98M	$13.95M
Orbimed advisors	3.22M	0.15%	3.22M	$6.44M
Pathstone	1.00M	0.01%	1.00M	$2.00M
Sphera funds management	820.00K	0.35%	820.00K	$1.64M
Boxer capital management	666.67K	0.42%	666.67K	$1.33M

Sold Out

Holder	Change
Qube research	-194.00
Ica group wealth management	-200.00
Wealthspire advisors	-1.13K
Jpmorgan chase	-3.27K
Citadel advisors	-3.50K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	42	-36.36%	13,317,824	-60.99%	20	0.76%	26	-39.53%	4	-20.00%
Sep 30, 2025	66	46.67%	34,138,461	213.66%	51	19.08%	43	115.00%	5	-37.50%
Jun 30, 2025	49	4.26%	11,823,806	13.72%	17	7.25%	22	4.76%	9	-18.18%
Mar 31, 2025	48	-4.00%	11,814,084	-51.88%	17	1.30%	21	-12.50%	13	-7.14%
Dec 31, 2024	49	16.67%	24,552,980	-14.38%	37	1.98%	24	71.43%	14	75.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Simplify Propel Opportunities ETF	2.83M	3.33%	1.84M
Biotech Growth Ord	474.28K	0.89%	-333.41K
BlackRock Credit Strategies Instl	231.56K	0.43%	-29.79K
LUNIS Biotech Growth Opp Fd I a	26.90K	0.05%	-
WEALTHGATE Biotech Fund Inst	26.90K	0.05%	26.90K
SPDR® S&P® International Small Cap ETF	18.73K	0.02%	-
Fidelity Nasdaq Composite Index	17.96K	0.02%	-
Dimensional Global Core Equity USD Acc	5.87K	0.01%	-
Dimensional Global Small Coms USD Acc	5.02K	0.01%	5.00
Dimensional World Equity GBP Acc	3.65K	0.01%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 26, 2026	Bharucha David	Chief Medical Officer	Sell	$23.63K
Dec 15, 2025	Bharucha David	Chief Medical Officer	Sell	$134.58K
Dec 15, 2025	Nelson Jeffrey Edward	Chief Operating Officer	Sell	$134.58K
Jan 26, 2026	Nelson Jeffrey Edward	Chief Operating Officer	Sell	$23.63K
Jan 26, 2026	Muller Lorenz	Chief Commercial Officer	Sell	$21.58K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	7
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-

MIST Ownership FAQ

Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals shareholders are primarily institutional investors at 20.06%, followed by 3.31% insiders and 76.63% retail investors. The average institutional ownership in Milestone Pharmaceuticals's industry, Biotech Stocks , is 384.56%, which Milestone Pharmaceuticals falls below.

Who owns the most shares of Milestone Pharmaceuticals?

Milestone Pharmaceuticals’s largest shareholders are Adage capital partners gp (6.98M shares, 10.51%), Blackrock (4.97M shares, 9.91%), and Propel bio management (4.12M shares, 6.20%). Together, they hold 26.63% of Milestone Pharmaceuticals’s total shares outstanding.

Does Blackrock own Milestone Pharmaceuticals?

Yes, BlackRock owns 9.91% of Milestone Pharmaceuticals, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.56M$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.48% of its assets in 658.55K Milestone Pharmaceuticals shares, valued at 1.32M$.

Who is the top mutual fund holder of Milestone Pharmaceuticals shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Milestone Pharmaceuticals shares, with 3.33% of its total shares outstanding invested in 2.83M Milestone Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools